Basic info
Industry
biotechnology research
Sectors
Biotechnology
Head and Neck Cancer Screening
Precision Molecular Diagnostics
Cervical Cancer Screening
Translational Genomics
SuperbDNA Technology
Colorectal Cancer Mutation Detection
XNA Technology
CLIA Lab
Whole Genome Sequencing
Cancer Mutation Detection
Precision Medicine
Early Cancer Detection
In-Vitro Diagnostics
NGS
CAR-T and Immuno therapy
HPV mRNA Test
Personalized Radiation Therapy
Genetics
Medical
Liquid Biopsy
Date founded
2012
Funding rounds raised
Total raised
$45M
from 2 investors over 2 rounds
D
DiaCarta, Inc. raised $45M on February 12, 2018
Investors: Fortune Fountain Capital
D
DiaCarta, Inc. raised $8M on January 9, 2015
Investors: BioVeda China Fund